Skip to main content

Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on Airway Microbiota

NIAID - National Institute of Allergy and Infectious Diseases

open
OpenLast verified: 2026-06-20

About This Grant

SUMMARY/ABSTRACT Dense microbial communities known as the microbiota are intimately associated with human health. Invading pathogens must overcome the microbiota to establish and successfully cause infections. In settings like the gastrointestinal tract, antagonistic interactions between microbes can strongly influence colonization outcomes. One highly prevalent pathway known to mediate these interactions the type VI secretion system (T6SS) which mediates contact-dependent killing via the translocation of toxic effector proteins into recipient cells. How the T6SS affects pathogen fitness and microbiota composition in other body sites, like the respiratory tract, is not well understood. A model disease for studying microbial ecology and interspecies interactions is Cystic Fibrosis, where polymicrobial communities of microorganisms colonize the respiratory tract due to defects in ion secretion and pathological mucus accumulation. Pseudomonas aeruginosa (Pa) causes chronic infections, dominates the airways of people with cystic fibrosis (pwCF) and is a major cause of morbidity and mortality. Pa harbors three T6SS with a variety of effectors delivered to host and bacterial competitors. We have recently reported that a T6SS effector, TseT, is delivered by the H2-T6SS and regulates microbial diversity in the upper respiratory tract of pwCF. In addition to TseT, the tseT operon encodes an immunity protein, TsiT, which our preliminary studies show also regulates Pa biofilm, in addition to its role as a bona fide immunity protein. TsiT has sequential and structural homology to general LysR-type transcriptional regulators (LTTR), which are known to regulate diverse genes including those involved in biofilm, metabolism, and quorum sensing. We have also identified diverse homologs for tsiT in a variety of Gram-negative organisms, including Burkholderiales. These results have led us to the overarching hypothesis that TsiT is a dual-function immunity protein that both regulates biofilm and neutralizes the TseT effector. In this proposal, we will define the mechanism by which TsiT regulates biofilm, investigate the evolution of tsiT homologs, and determine their impact on microbial ecology in polymicrobial communities in the respiratory tract. To this end, we propose three aims: 1) Test the hypothesis that TsiT is a transcriptional regulator that mediates Pa biofilm; 2) Test the hypothesis that tsiT diversity outside of P. aeruginosa confers protection against Pa TseT intoxication; 3) Test the hypothesis that tsiT genes modulate P. aeruginosa fitness during biofilm growth in a model CF respiratory microbiota.

Grant Summary

Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on Airway Microbiota is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $825K for university, nonprofit, healthcare org. Applications are due 2031-01-31 (open). Check eligibility and apply with FindGrants.

Focus Areas

health research

Eligibility

universitynonprofithealthcare org

How to Apply

Funding Range

Up to $825K

Deadline

2031-01-31

Complexity
High
  1. 1Confirm your organization is eligible for Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on Airway Microbiota from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
  2. 2Gather the required documents and information, including your organization details, project plan, and budget figures.
  3. 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
  4. 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
This record is a past award, contract, or funder profile — useful for research, but not an open grant application. Check the original source for current opportunities from this funder.

Don't want to draft it yourself?

We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.

AI Requirement Analysis

Detailed requirements not yet analyzed

Have the NOFO? Paste it below for AI-powered requirement analysis.

0 characters (min 50)

Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on Airway Microbiota: Frequently Asked Questions

Who is eligible for the Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on Airway Microbiota?

Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on Airway Microbiota is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.

How much funding does the Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on Airway Microbiota provide?

Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on Airway Microbiota provides up to $825K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.

When is the Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on Airway Microbiota deadline?

Applications for Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on Airway Microbiota are due 2031-01-31 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.

How do you apply for the Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on Airway Microbiota?

To apply for Impact of a Dual Function Type VI Secretion System (T6SS) Immunity Protein on Airway Microbiota, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.

Browse More Grants